N Latex FLC kappa, N Latex FLC lambda

FDA 510(k) K193047 · Siemens Healthcare Diagnostics Products GmbH

Substantially Equivalent

510(k) numberK193047

Submission

Device name
N Latex FLC kappa, N Latex FLC lambda
Applicant
Siemens Healthcare Diagnostics Products GmbH
Marburg, DE
Received
November 1, 2019
Decision date
July 14, 2021
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
DFH – Kappa, Antigen, Antiserum, Control
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5550
Specialty
Immunology

Other 510(k)s with product code DFH

510(k)DeviceApplicantDecision
K253358Diazyme Human Kappa (k) Free Light Chain Assay; Diazyme Human Lambda (¿) Free Light…DFH · Traditional Diazyme Laboratories, Inc.12/19/2025SE
K250549Optilite® Freelite Mx Kappa Free Kit; Optilite® Freelite Mx Lambda Free KitDFH · Traditional The Binding Site Group , Ltd.05/23/2025SE
K231601FLC Kappa, FLC Lambda,FLC Control Level 1, FLC Control Level 2DFH · Traditional Sebia02/23/2024SE
K231290Optilite® Freelite® Kappa Free Kit, Optilite® Freelite® Lambda Free KitDFH · Traditional The Binding Site, Ltd.01/24/2024SE
K210623FLC Kappa, FLC Lambda, FLC Control Level 1, FLC Control Level 2DFH · Traditional Sebia11/18/2022SE
K211648Diazyme Human Kappa Free Light Chain Assay, Diazyme Human Lambda Free Light Chain AssayDFH · Traditional Diazyme Laboratories, Inc.09/08/2022SE
K220001Diazyme Human Kappa Free Light Chain Assay, Diazyme Human Lambda Free Light Chain AssayDFH · Traditional Diazyme Laboratories, Inc.08/04/2022SE
K212379N Latex FLC kappa, N Latex FLC lambdaDFH · Traditional Siemens Healthcare Diagnostics Products GmbH03/02/2022SE
K201496N Latex FLC kappa, N Latex FLC lambdaDFH · Traditional Siemens Healthcare Diagnostics Products GmbH10/29/2021SE
K190879N Latex FLC kappa, N Latex FLC lambdaDFH · Special Siemens Healthcare Diagnostics Products GmbH05/03/2019SE

More from Siemens Healthcare Diagnostics Products GmbH

510(k)DeviceDecision
K260331IMMULITE 2000 3gAllergy Specific IgE Vantage; IMMULITE 2000 Systems Peanut Allergen (F13)DHB · Traditional 09/04/2026SE
K240315INNOVANCE Anti-Xa (OPPU05); INNOVANCE Apixaban Standards (OPPW05); INNOVANCE Apixaban…QLU · Traditional 10/10/2024SE
K233946Immulite® 2000 Br-MaMOI · Traditional 03/13/2024SE
K233663N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)CFN · Special 12/13/2023SE
K213510Immulite/Immulite 1000 Om-Ma, Immulite 2000 Om-MaLTK · Traditional 09/08/2023SE
K220728vWF AgGGP · Traditional 06/02/2023SE
K212559CardioPhase® hsCRPNQD · Special 12/16/2022SE
K212379N Latex FLC kappa, N Latex FLC lambdaDFH · Traditional 03/02/2022SE
K201496N Latex FLC kappa, N Latex FLC lambdaDFH · Traditional 10/29/2021SE
K203270IMMULITE/IMMULITE® 1000 CortisolCGR · Traditional 01/15/2021SE

Questions and answers

When was N Latex FLC kappa, N Latex FLC lambda cleared by the FDA?

N Latex FLC kappa, N Latex FLC lambda (K193047) received a 510(k) decision of Substantially Equivalent on July 14, 2021, 621 days after the submission was received.

What is the product code of K193047?

The FDA product code is DFH – Kappa, Antigen, Antiserum, Control, a Class II (moderate risk) device regulated under 21 CFR 866.5550.